在p16+宫转移的未知初级真癌 (tCUP) 中的生存结果
Muhammad Faisal1,2, Nguyen-Son Le3, Stefan Grasl3
1Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.
International archives of otorhinolaryngology
|October 25, 2023
概括
宫淋巴结转移中的p16过度表达是未知初级癌症 (CUP) 中改善无复发生存率 (RFS) 的重要预测因素. 这一发现表明p16阳性可能引导CUP患者的治疗决策.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 未知初级癌症 (CUP) 存在诊断方面的挑战.
- 年龄和淋巴结比率是CUP中确定的预后因素.
研究的目的:
- 为了评估p16过度表达的预后价值在没有确定的原发性瘤的CUP患者.
- 确定p16状态是否影响整体存活率 (OS) 和无复发存活率 (RFS).
主要方法:
- 对43名CUP患者进行治疗性淋巴结解剖 (LND) 的回顾性分析.
- 免疫组织化学用于评估p16过度表达.
- 考克斯比例危险回归分析应用于生存数据.
主要成果:
- 确定p16阳性是区域无复发生存期 (RRFS) 的独立预测因子 (HR 6.180).
- 复发的中位时间为10个月,死亡的中位时间为25个月.
- 临床病理学数据,不包括p16状态,并没有显著影响5年的OS或RFS.
结论:
- 宫转移与p16过度表达表明CUP手术后RFS得到改善.
- 淋巴结p16的阳性值得进一步调查,作为CUP的预后标志物.
相关概念视频
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


